MacroGenics, Inc. (MGNX)
$3.72-0.53%Close
SELLRECOVERY · day 2
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $236M
- Beta
- 1.21
- P/E (TTM)
- -16.55
- Short % float
- 12.60%
- Days to cover
- 10.9
- SI change
- +0.1%
- 1W
- -1.33%
- 1M
- -7.00%
- vs SPY 1W
- -1.75%
- vs SPY 1M
- -9.06%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on MGNX?
- LOPJLB’s latest quantitative signal on MacroGenics, Inc. (MGNX) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is MGNX in?
- MacroGenics, Inc. (MGNX) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does MacroGenics, Inc. (MGNX) do?
- MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics for the treatment of cancer in the United States. The companyâs product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4 for the treatment of mCRPC and docetaxel that is in phase 2 clinical…